伟科(VICL)

0.676 %

今开:昨收:0.676
最高:最低:
涨停价:跌停价:
总市值:15440704

伟科的热门评论

淘沙见金06-03 18:52

$伟科(VICL)$ 盘前宣布合并消息,股价暴涨至1.5。面包老师这把50%收益妥妥的 @黑色面包 SAN DIEGO and BOULDER, Colo., June 03, 2019 (GLOBE NEWSWIRE) -- Vical Incorporated (“Vical”) (Nasdaq:VICL) and Brickell Biotech, Inc. (“Brickell”), a privately-held clinical-stage medical de...

VICL:等待被借壳上市的优质烟蒂股

淘沙见金03-25 10:10

投资美股生物医药,除了可以体验赌临床数据这种如同坐云霄飞车一般的酸爽,也可以平平淡淡老老实实的捡捡烟屁股。大多数小药股都脱离不了当炮灰的宿命,因此小药股里面这种市值低于净资产的公司还挺多,比如今天要介绍的VICL$伟科(VICL)$ . 公司没什么好介绍的,现在手里的现金差不多45M-50M,折合...

Efficacious03-26 00:59

VICL 近期可能被借壳,安全边际较高,预期收益20%-50%

淘沙见金04-09 09:27

$伟科(VICL)$ BVF从13D变成了13G,持有的股本数量没有变化,难道是之前13D的目的已经到达?近期宣布合并的对象?The Reporting Persons believe that the Issuer remains undervalued and that additional value could be realized through pursuing a variety of strategic alternatives and pat...

伟科的最新评论

淘沙见金06-03 18:52

$伟科(VICL)$ 盘前宣布合并消息,股价暴涨至1.5。面包老师这把50%收益妥妥的 @黑色面包 SAN DIEGO and BOULDER, Colo., June 03, 2019 (GLOBE NEWSWIRE) -- Vical Incorporated (“Vical”) (Nasdaq:VICL) and Brickell Biotech, Inc. (“Brickell”), a privately-held clinical-stage medical de...查看全文

淘沙见金04-09 09:27

$伟科(VICL)$ BVF从13D变成了13G,持有的股本数量没有变化,难道是之前13D的目的已经到达?近期宣布合并的对象?The Reporting Persons believe that the Issuer remains undervalued and that additional value could be realized through pursuing a variety of strategic alternatives and pat...查看全文

VICL:等待被借壳上市的优质烟蒂股

淘沙见金03-25 10:10

投资美股生物医药,除了可以体验赌临床数据这种如同坐云霄飞车一般的酸爽,也可以平平淡淡老老实实的捡捡烟屁股。大多数小药股都脱离不了当炮灰的宿命,因此小药股里面这种市值低于净资产的公司还挺多,比如今天要介绍的VICL$伟科(VICL)$ . 公司没什么好介绍的,现在手里的现金差不多45M-50M,折合...查看全文

伟科的公告

$伟科(VICL)$ 8-K - Current report Filed: 2019-09-03 AccNo: 0000819050-19-000006 Size: 6 MBItem 1.01: Entry into a Material Definitive AgreementItem 2.01: Completion of Acquisition or Disposition of AssetsItem 3.02: Unregistered Sales of Equity SecuritiesItem 3.03: Material Mo...

$伟科(VICL)$ 8-K - Current report Filed: 2019-08-30 AccNo: 0001193125-19-234921 Size: 28 KBItem 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain OfficersItem 5.03: Amendments to Arti...

$伟科(VICL)$ DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material Filed: 2019-08-23 AccNo: 0001193125-19-227897 Size: 60 KB 网页链接

$伟科(VICL)$ DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material Filed: 2019-08-21 AccNo: 0001193125-19-226132 Size: 40 KB 网页链接

$伟科(VICL)$ 8-K - Current report Filed: 2019-08-21 AccNo: 0001193125-19-226131 Size: 41 KBItem 1.01: Entry into a Material Definitive AgreementItem 9.01: Financial Statements and Exhibits 网页链接

$伟科(VICL)$ DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material Filed: 2019-08-20 AccNo: 0001193125-19-224887 Size: 298 KB 网页链接

$伟科(VICL)$ DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material Filed: 2019-08-08 AccNo: 0001193125-19-215937 Size: 18 KB 网页链接

$伟科(VICL)$ 8-K - Current report Filed: 2019-07-18 AccNo: 0001564590-19-025189 Size: 35 KBItem 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing 网页链接

$伟科(VICL)$ DEFM14A - Definitive proxy statement relating to merger or acquisition Filed: 2019-07-12 AccNo: 0001193125-19-193297 Size: 3 MB 网页链接